SERA
Sera Prognostics Inc
NASDAQ: SERA · HEALTHCARE · MEDICAL DEVICES
$1.99
+0.51% today
Updated 2026-04-29
Market cap
$77.93M
P/E ratio
—
P/S ratio
962.05x
EPS (TTM)
$-0.67
Dividend yield
—
52W range
$1 – $4
Volume
0.1M
Sera Prognostics Inc (SERA) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | $23.26M | $14.80M | $147.03M | $116.33M | $95.44M | $72.58M |
| Cash & equivalents | $21.39M | $13.53M | $58.93M | $29.88M | $3.88M | $4.04M |
| Current assets | $21.55M | $13.73M | $110.25M | $90.13M | $61.34M | $47.60M |
| Total liabilities | $12.30M | $11.86M | $8.46M | $17.39M | $25.28M | $24.77M |
| Current liabilities | $5.90M | $11.24M | $8.41M | $15.54M | $24.44M | $24.77M |
| Long-term debt | $5.44M | $348000.00 | — | — | — | — |
| Shareholder equity | $10.96M | $2.94M | $138.56M | $98.94M | $70.16M | $47.80M |
| Retained earnings | $-111.61M | $-131.46M | $-166.47M | $-210.65M | $-246.90M | $-279.79M |
| Accounts receivable | $1000.00 | $2000.00 | $3.14M | $6.11M | $11.47M | $34000.00 |
| Inventory | $1.00 | — | — | $1.00 | — | — |
| Goodwill | — | — | — | — | — | — |